Total Payments
$70,439
2024 Payments
$65,007
Companies
40
Transactions
148
Medicare Patients
82
Medicare Billing
$8,979
Payment Breakdown by Category
Consulting$54,358 (77.2%)
Other$8,865 (12.6%)
Food & Beverage$5,133 (7.3%)
Travel$1,888 (2.7%)
Education$194.95 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $54,358 | 13 | 77.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $8,865 | 4 | 12.6% |
| Food and Beverage | $5,133 | 123 | 7.3% |
| Travel and Lodging | $1,888 | 6 | 2.7% |
| Education | $194.95 | 2 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Tempus AI, Inc | $41,944 | 14 | $0 (2024) |
| EMD Serono, Inc. | $11,997 | 4 | $0 (2024) |
| Ipsen Biopharmaceuticals, Inc | $8,953 | 8 | $0 (2024) |
| PFIZER INC. | $1,859 | 7 | $0 (2024) |
| Genmab U.S., Inc. | $1,393 | 3 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $697.77 | 10 | $0 (2024) |
| Janssen Biotech, Inc. | $475.27 | 13 | $0 (2024) |
| ABBVIE INC. | $344.24 | 4 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $267.00 | 6 | $0 (2024) |
| Gilead Sciences, Inc. | $245.86 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $65,007 | 104 | Tempus AI, Inc ($41,944) |
| 2023 | $4,514 | 35 | Ipsen Biopharmaceuticals, Inc ($3,450) |
| 2022 | $707.77 | 6 | AstraZeneca Pharmaceuticals LP ($233.80) |
| 2021 | $106.19 | 2 | Amgen Inc. ($95.00) |
| 2019 | $103.29 | 1 | E.R. Squibb & Sons, L.L.C. ($103.29) |
All Payment Transactions
148 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Pharmacosmos Therapeutics Inc. | MONOFERRIC (Drug) | Food and Beverage | In-kind items and services | $14.14 | General |
| Category: HEMATOLOGY | ||||||
| 12/13/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $93.42 | General |
| Category: Oncology | ||||||
| 12/13/2024 | PharmaEssentia USA Corporation | BESREMI (Drug) | Food and Beverage | In-kind items and services | $24.01 | General |
| Category: Oncology | ||||||
| 12/12/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: Oncology | ||||||
| 12/09/2024 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Food and Beverage | Cash or cash equivalent | $34.10 | General |
| Category: Oncology / Rare Diseases | ||||||
| 11/25/2024 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: ONCOLOGY | ||||||
| 11/20/2024 | Boston Scientific Corporation | TheraSphere Y90 Glass Microspheres 10 GBq (Device) | Food and Beverage | In-kind items and services | $20.53 | General |
| Category: TheraSphere_PI | ||||||
| 11/18/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $116.15 | General |
| 11/18/2024 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Food and Beverage | In-kind items and services | $29.85 | General |
| Category: Oncology | ||||||
| 11/14/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $1.72 | General |
| Category: Immunology | ||||||
| 11/07/2024 | Tempus AI, Inc | XT CDX (Device) | Food and Beverage | In-kind items and services | $123.57 | General |
| Category: NONE | ||||||
| 10/30/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $12.87 | General |
| Category: Oncology | ||||||
| 10/26/2024 | Genmab U.S., Inc. | Epkinly (Drug) | Consulting Fee | Cash or cash equivalent | $1,332.50 | General |
| Category: Oncology | ||||||
| 10/26/2024 | Genmab U.S., Inc. | Epkinly (Drug) | Food and Beverage | In-kind items and services | $53.45 | General |
| Category: Oncology | ||||||
| 10/26/2024 | Genmab U.S., Inc. | Epkinly (Drug) | Travel and Lodging | Cash or cash equivalent | $6.70 | General |
| Category: Oncology | ||||||
| 10/25/2024 | PFIZER INC. | PADCEV (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,620.00 | General |
| Category: Oncology | ||||||
| 10/24/2024 | Gilead Sciences, Inc. | Trodelvy (Drug) | Food and Beverage | In-kind items and services | $114.00 | General |
| Category: ONC | ||||||
| 10/24/2024 | Janssen Biotech, Inc. | CARVYKTI (Drug) | Food and Beverage | In-kind items and services | $92.46 | General |
| Category: Oncology | ||||||
| 10/20/2024 | Tempus AI, Inc | — | Consulting Fee | Cash or cash equivalent | $4,000.00 | General |
| 10/18/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: Oncology | ||||||
| 10/17/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $0.86 | General |
| Category: Immunology | ||||||
| 10/16/2024 | Pharmacosmos Therapeutics Inc. | MONOFERRIC (Drug) | Food and Beverage | In-kind items and services | $24.89 | General |
| Category: HEMATOLOGY | ||||||
| 10/14/2024 | TerSera Therapeutics LLC | Zoladex (Drug) | Food and Beverage | In-kind items and services | $31.80 | General |
| Category: Oncology | ||||||
| 10/11/2024 | Deciphera Pharmaceuticals Inc. | QINLOCK (Drug), TGCT | Food and Beverage | In-kind items and services | $23.53 | General |
| Category: ONCOLOGY | ||||||
| 10/08/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $21.58 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 66 | 132 | $29,737 | $7,217 |
| 2020 | 1 | 16 | 16 | $8,144 | $1,763 |
Total Patients
82
Total Services
148
Medicare Billing
$8,979
Procedure Codes
4
All Medicare Procedures & Services
4 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 27 | 54 | $22,343 | $5,373 | 24.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $5,754 | $1,334 | 23.2% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 28 | 67 | $1,640 | $509.87 | 31.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 16 | 16 | $8,144 | $1,763 | 21.6% |
About Dr. Mahran Shoukier, MD
Dr. Mahran Shoukier, MD is a Internal Medicine healthcare provider based in Galveston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/11/2012. The National Provider Identifier (NPI) number assigned to this provider is 1659633154.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mahran Shoukier, MD has received a total of $70,439 in payments from pharmaceutical and medical device companies, with $65,007 received in 2024. These payments were reported across 148 transactions from 40 companies. The most common payment nature is "Consulting Fee" ($54,358).
As a Medicare-enrolled provider, Shoukier has provided services to 82 Medicare beneficiaries, totaling 148 services with total Medicare billing of $8,979. Data is available for 2 years (2020–2023), covering 4 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Hematology & Oncology
- Location Galveston, TX
- Active Since 06/11/2012
- Last Updated 06/09/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1659633154
Products in Payments
- Tazverik (Drug) $8,938
- PADCEV (Biological) $1,743
- Epkinly (Drug) $1,393
- EPKINLY (Drug) $344.24
- Trodelvy (Drug) $210.19
- IMBRUVICA (Drug) $160.48
- CALQUENCE (Drug) $159.05
- ENHERTU (Biological) $158.71
- TAGRISSO (Drug) $142.34
- Optune (Device) $140.22
- RYBREVANT (Drug) $136.88
- TUKYSA (Drug) $125.00
- XT CDX (Device) $123.57
- PEMAZYRE (Drug) $122.30
- DARZALEX (Biological) $120.97
- XPOVIO (Drug) $119.99
- CARVYKTI (Drug) $116.14
- EMPLICITI (Biological) $103.29
- Fabhalta (Drug) $101.90
- OPDIVO (Biological) $100.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Galveston
Tina Kochar, Md, MD
Internal Medicine — Payments: $236,481
Internal Medicine $236,481
Dr. Umamahesh Rangasetty, Mbbs, MBBS
Internal Medicine — Payments: $106,903
Internal Medicine $106,903
Dr. Dustin Staloch, M.d, M.D
Internal Medicine — Payments: $30,925
Internal Medicine $30,925
Christopher Perez, M.d, M.D
Internal Medicine — Payments: $20,081
Internal Medicine $20,081
Tejo Musunuru, M.d, M.D
Internal Medicine — Payments: $17,724
Internal Medicine $17,724
Haider Al Taii, Md, MD
Internal Medicine — Payments: $16,439
Internal Medicine $16,439